- Home
- MCRB vs NA Comparison
MCRB vs NA Comparison
Compare MCRB & NA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCRB
- NA
- Stock Information
- Founded
- MCRB 2010
- NA 2019
- Country
- MCRB United States
- NA China
- Employees
- MCRB N/A
- NA N/A
- Industry
- MCRB Biotechnology: Pharmaceutical Preparations
- NA Semiconductors
- Sector
- MCRB Health Care
- NA Technology
- Exchange
- MCRB Nasdaq
- NA Nasdaq
- Market Cap
- MCRB 72.0M
- NA 77.6M
- IPO Year
- MCRB 2015
- NA 2022
- Fundamental
- Price
- MCRB $7.63
- NA $12.17
- Analyst Decision
- MCRB Hold
- NA
- Analyst Count
- MCRB 4
- NA 0
- Target Price
- MCRB $73.67
- NA N/A
- AVG Volume (30 Days)
- MCRB 75.0K
- NA 390.5K
- Earning Date
- MCRB 08-12-2025
- NA 03-25-2025
- Dividend Yield
- MCRB N/A
- NA N/A
- EPS Growth
- MCRB N/A
- NA N/A
- EPS
- MCRB 8.98
- NA N/A
- Revenue
- MCRB N/A
- NA $5,561,770.00
- Revenue This Year
- MCRB N/A
- NA N/A
- Revenue Next Year
- MCRB N/A
- NA N/A
- P/E Ratio
- MCRB $0.89
- NA N/A
- Revenue Growth
- MCRB N/A
- NA N/A
- 52 Week Low
- MCRB $6.53
- NA $2.75
- 52 Week High
- MCRB $30.60
- NA $13.86
- Technical
- Relative Strength Index (RSI)
- MCRB 48.66
- NA 76.74
- Support Level
- MCRB $7.25
- NA $7.75
- Resistance Level
- MCRB $7.89
- NA $12.94
- Average True Range (ATR)
- MCRB 0.46
- NA 1.91
- MACD
- MCRB 0.11
- NA 0.44
- Stochastic Oscillator
- MCRB 60.23
- NA 88.48
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
About NA Nano Labs Ltd
Nano Labs Ltd operates as a fabless IC design company and product solution provider in China. It engages in the development of HTC chips, HPC chips, distributed computing and storage solutions, smart-NICs, vision computing chips, and distributed rendering. Its products comprise Cuckoo 1.0 Chip, Cuckoo 2.0 Chip, and Darkbird 1.0 Chip. Majority of the company revenue comes from China.